EBRAINS – Trademark Portfolio
Entity Type: 99
EBRAINS holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 6 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include EBRAINS.
Chaussée de La Hulpe 166
Glaverbel 1er étage Section B B-1000 Bruxelles
Showing of trademarks Trademarks
Trademark Classifications
EBRAINS's trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Education; providing of training; entertainment; sporting and cultural activities
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does EBRAINS have?
EBRAINS has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does EBRAINS file in?
EBRAINS files trademarks across 6 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 16 (Paper Goods). Class 35 covers advertising; business management; business administration; office functions.
What are EBRAINS's most well-known trademarks?
EBRAINS's registered trademark portfolio includes well-known marks such as EBRAINS. These are among 1 currently registered trademark in the portfolio.
What is EBRAINS's trademark registration success rate?
EBRAINS has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.